Stock data
AnaptysBio, Inc. (ANAB)
AnaptysBio, Inc. (ANAB) reported revenue of US$234.60M and net income of -US$13.23M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$234.60M | — | US$47.90M | -US$13.23M | — |
| 2024 | US$91.28M | — | -US$114.95M | -US$145.23M | — |
| 2023 | US$17.16M | — | -US$164.41M | -US$163.62M | — |
| 2022 | US$10.29M | — | -US$115.15M | -US$128.72M | — |
| 2021 | US$63.17M | — | -US$56.81M | -US$57.80M | — |
Quarterly results
Data as of 2026-03-31
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-03-31 | US$25.56M | -US$52.88M | — |
| 2025-12-31 | US$108.25M | US$49.61M | — |
| 2025-09-30 | US$76.32M | US$15.11M | — |
| 2025-06-30 | US$22.26M | -US$38.63M | — |
| 2025-03-31 | US$27.77M | -US$39.33M | — |
| 2024-12-31 | US$43.11M | -US$21.78M | — |
| 2024-09-30 | US$30.02M | -US$32.85M | — |
| 2024-06-30 | US$10.97M | -US$46.66M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.